Roche pharma CEO Anderson talks up Vabysmo’s ‘very strong launch’ plans as Eylea battle looms badams Wed, 02/09/2022 – 09:54 More: Roche pharma CEO Anderson talks up Vabysmo’s 'very strong launch' plans as Eylea battle looms Source: fierce
read moreKaryopharm ready to take new Xpovio indication to the FDA but analysts hold out for details esagonowsky Wed, 02/09/2022 – 08:46 More: Karyopharm ready to take new Xpovio indication to the FDA but analysts hold out for details Source: fierce
read moreSMC accepts promising new therapy which offers a better quality of life to patients with epilepsy More: Angelini Pharma’s Ontozry available for patients in Scotland with drug-resistant epilepsy Source: News
read moreSustainable lateral flow test kits developed in Birmingham reduce plastic and boost self-testing through ease of use More: Let it Flow: COVID-19 LFT passes UK government assessment Source: News
read moreAmgen talks long-term growth, but doubts remain for analysts, investors kdunleavy Tue, 02/08/2022 – 14:41 More: Amgen talks long-term growth, but doubts remain for analysts, investors Source: fierce
read moreJ&J pauses COVID-19 vaccine production at Dutch plant in temporary pivot to RSV shot: NYT fkansteiner Tue, 02/08/2022 – 13:51 More: J&J pauses COVID-19 vaccine production at Dutch plant in temporary pivot to RSV shot: NYT Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals